시장보고서

상품코드

2075283

갱년기 치료 시장 : 치료 유형별, 투여 경로별, 제형별, 적응증별, 유통 채널별, 지역별

Global Menopause Treatment Market, By Treatment Type, By Route of Administration, By Form, By Indication, By Distribution Channel, By Geography

발행일: 2026년 04월 | 리서치사: 구분자

Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

가격

Unprintable PDF & Excel (Single User License)

PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,500

￦ 6,719,000

PDF & Excel (Multi User License - Up to 7 Users)

PDF & Excel 보고서를 동일 기업 최대 7명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능하며, 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

US $ 7,000

￦ 10,453,000

PDF & Excel (Corporate User License)

PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000

￦ 14,933,000

※ 부가세 별도

한글목차

영문목차

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 갱년기 치료 시장은 2026년에 161억 9,000만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 248억 3,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 6.3%로 성장할 것으로 전망되고 있습니다.

리포트 범위		리포트 상세
기준연도 :	2025년	2026년 시장 규모 :	161억 9,000만 달러
과거 데이터 기간 :	2020-2024년	예측 기간 :	2026-2033년
2026-2033년 예측 기간의 CAGR :	6.30%	2033년 시장 규모 예측 :	248억 3,000만 달러

갱년기는 일반적으로 45세에서 55세 사이의 여성에게 나타나는 자연스러운 생물학적 과정입니다. 이는 여성의 가임기 종료를 알리며, 가임기 이후의 삶으로의 전환을 의미합니다. 갱년기의 가장 흔한 징후와 증상으로는 생리 불순, 안면 홍조, 야간 발한, 질 건조, 기분 변화, 수면 장애 등이 있습니다. 갱년기가 진행됨에 따라 여성의 에스트로겐 농도는 급격히 감소하며, 이를 방치할 경우 몇 가지 장기적인 건강 위험으로 이어질 수 있습니다. 따라서 이 과도기 동안의 증상 관리는 많은 여성들에게 최우선 과제입니다. 전 세계 갱년기 치료 시장에서는 갱년기 증상으로 고통받는 여성들을 위해 다양한 치료 옵션이 제공되고 있습니다.

시장 역학 :

생활 방식의 변화와 건강에 대한 의식의 향상로 인해 여성의 갱년기 장애 유병률이 증가하고 있는 것이 전 세계 갱년기 치료 시장의 성장을 이끄는 주요 요인이 되고 있습니다. 수많은 조사에 따르면 40세에서 60세 사이의 여성 중 약 4분의 1이 갱년기와 관련된 문제를 일으키는 증상을 적어도 하나 이상 경험한 것으로 보고되고 있습니다. 또한 앉아서 하는 업무가 늘어나고 신체 활동이 부족해진 것도 조기 폐경 위험을 높이고 있습니다. 또한 대형 제약사의 신제품 승인 및 출시로 인해 갱년기 혈관운동 증상을 치료하기 위한 선택지가 넓어지고 있습니다. 그러나 호르몬 대체요법에 따른 부작용과 대체 치료법의 존재로 인해 여전히 시장의 잠재력이 어느 정도 제한받고 있습니다. 또한 개발도상국에서 치료에 대한 인식이 낮은 점은 시장 관계자들에게 과제가 되고 있습니다. 그렇긴 하지만, 갱년기 관리 분야의 기술 발전과 아시아태평양의 의료 관광 확대에 힘입어, 향후 수년간 이해관계자들에게 큰 비즈니스 기회가 열릴 것으로 예상됩니다.

본 조사의 주요 특징 :

이 조사에서는 다양한 부문의 잠재적 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
이 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 갱년기 치료 시장의 주요 기업 개요을 소개하고 있습니다.
이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
이 '세계의 갱년기 치료 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
이해관계자들은 세계 갱년기 치료 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 원활하게 진행할 수 있을 것입니다.

Report Coverage	Report Details
Base Year:	2025	Market Size in 2026:	USD 16.19 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.30%	2033 Value Projection:	USD 24.83 Bn

Menopause is a natural biological process that usually occurs between the ages of 45 to 55 years in women. It marks the end of a woman's reproductive years and the transition into her post-reproductive life. Some of the most common signs and symptoms of menopause include irregular menstrual periods, hot flashes, night sweats, vaginal dryness, mood changes, and difficulty sleeping. As menopause progresses, a woman's estrogen levels drop dramatically, which could lead to several long-term health risks if left untreated. Therefore, managing symptoms during this transitional phase has become a priority for many women. The global menopause treatment market offers a variety of treatment options for women suffering from menopause symptoms.

Market Dynamics:

The rising prevalence of menopause issues among women owing to changing lifestyle patterns and growing health awareness levels is a key factor driving the growth of global menopause treatment market. Numerous researches have shown that approximately one-fourth of women within the age group of 40 to 60 years report experiencing at least one problematic symptom associated with menopause. There is also the emergence of sedentary jobs and a lack of physical activity, which has escalated the risks of premature or early menopause. Additionally, new product approvals and launches by leading pharmaceutical players are expanding the treatment choices for addressing vasomotor symptoms during menopause. However, side effects associated with hormone replacement therapy and the availability of alternative treatment options still limit the market potential to a certain extent. Moreover, a lack of awareness about treatment in developing nations poses a challenge to market players. Nonetheless, technological advancements in menopausal care and growing medical tourism in the Asia Pacific region are expected to unlock lucrative opportunities for stakeholders in coming years.

Key Features of the Study:

It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global menopause treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Novartis AG, Pfizer Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Novo Nordisk A/S, illendo Therapeutics, Inc., Mithra Pharmaceuticals, Merck & Co., Inc, Cipla Inc., Abbott, Viatris Inc., Organon, SnapNurse, Glenmark Pharmaceuticals Limited, Procter & Gamble, Duchesnay USA., TherapeuticsMD, Inc., Avion Pharmaceuticals, KWS, PharmaCare Europe Ltd., Amneal Pharmaceuticals LLC.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global menopause treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global menopause treatment market

Detailed Segmentation:

Global Menopause Treatment Market, By Treatment Type (Revenue, USD Bn, 2021 - 2033)
Hormone Therapy
- Estrogen-based Drugs
- Progestin-based Drugs
- Combination Drugs (Estrogen and Progestin, Estrogen and Other Medicines)
Non-hormonal Therapy
- Neurokinin 3 (NK3)
- Receptor Antagonist
- Selective Serotonin
- Reuptake Inhibitor (SSRI)
- Others
Others
Global Menopause Treatment Market, By Route of Administration (Revenue, USD Bn, 2021 - 2033)
Oral
Topical
Parenteral
Vaginal
Others
Global Menopause Treatment Market, By Form (Revenue, USD Bn, 2021 - 2033)
Tablets
Creams
Patches
Pessaries
Injections
Others
Global Menopause Treatment Market, By Indication (Revenue, USD Bn, 2021 - 2033)
Perimenopause
Menopause
Postmenopause
Global Menopause Treatment Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Specialty Stores
Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Top Companies in the Global Menopause Treatment Market:
Novartis AG
Pfizer Inc.
Bayer AG
Teva Pharmaceutical Industries Ltd.
AbbVie Inc.
Novo Nordisk A/S
illendo Therapeutics, Inc.
Mithra Pharmaceuticals
Merck & Co., Inc
Cipla Inc.
Abbott
Viatris Inc.
Organon
Glenmark Pharmaceuticals Limited
Procter & Gamble
Duchesnay USA.
TherapeuticsMD, Inc.
Avion Pharmaceuticals
KWS
PharmaCare Europe Ltd.
Amneal Pharmaceuticals LLC.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Treatment Type
- Market Snippet, By Route of Administration
- Market Snippet, By Form
- Market Snippet, By Indication
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- New Product Launches
- Rising Geriatric Population
- Financial Support Through Funding And Investments
Impact Analysis
Key Highlights
Market Trends
PEST Analysis
Regulatory Scenario
Mergers, Acquisitions, and Collaborations
Key Services Offered
Treatment cost Analysis
Identification of Top Market Players
Government Initiatives and Investments
Brand Mapping & Pricing Analysis
Healthcare Spending by Country

4. Global Menopause Treatment Market, By Treatment Type, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hormone Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  - Estrogen-based Drugs
  - Progestin-based Drugs
  - Combination Drugs (Estrogen and Progestin, Estrogen and Other Medicines)
Non-hormonal Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  - Neurokinin 3 (NK3)
  - Receptor Antagonist
  - Selective Serotonin
  - Reuptake Inhibitor (SSRI)
  - Others
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

5. Global Menopause Treatment Market, By Route of Administration, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Vaginal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

6. Global Menopause Treatment Market, By Form, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Creams
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Patches
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Pessaries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

7. Global Menopause Treatment Market, By Indication, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Perimenopause
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Menopause
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Postmenopause
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

8. Global Menopause Treatment Market, By Distribution Channel, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Specialty Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

9. Global Menopause Treatment Market, By Region, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, By Region/Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region/Country, 2022 - 2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

10. Competitive Landscape

Company Profile
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Bayer AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- AbbVie Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Novo Nordisk A/S
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- illendo Therapeutics, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Mithra Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Merck & Co., Inc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Cipla Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Abbott
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Viatris Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Organon
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- SnapNurse
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Glenmark Pharmaceuticals Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Procter & Gamble
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Duchesnay USA.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- TherapeuticsMD, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Avion Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- KWS
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- PharmaCare Europe Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Amneal Pharmaceuticals LLC.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
Analyst Views

11. Section

References
Research Methodology
About us

갱년기 치료 시장 : 치료 유형별, 투여 경로별, 제형별, 적응증별, 유통 채널별, 지역별